A Quick Guidelien for Drug Evaluation and Selection in Chinese Medical Institutions(2nd Edition)

Title: A Quick Guidelien for Drug Evaluation and Selection in Chinese Medical Institutions(2nd Edition)
Edition: Updated
Classification: Rapid advice guideline
Field: Others
Countries and regions: China
Guidelines users: 医疗机构药事管理与药物治疗学委员会(小组)、药师、医师等相关人员及相关政府部门制定药物物政策的技术参考。
Evidence classification method: GRADE
Development unit: Department of Pharmacy Beijing Tiantan Hospital Affiliated to Capital Medical University
Registration time: 2022-06-01
Registration number: IPGRP-2022CN301
Purpose of the guideline: To guide medical institutions to carry out the drug evaluation and selection process, to enhance people's feeling, a sense of security, happiness, for the catalog of national essential drugs and the national basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue (hereinafter referred to as the catalog of national medical insurance) of drugs and new drugs, leading application at home and abroad, the authority of the technology and method, Scientific evaluation and selection were carried out, and "Essential Drug Supply Catalogue" and "Prescription Collection" were formulated reasonably in medical institutions to promote rational clinical drug use.